- Home
- PRPO vs EVGN Comparison
PRPO vs EVGN Comparison
Compare PRPO & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- EVGN
- Stock Information
- Founded
- PRPO N/A
- EVGN 1999
- Country
- PRPO United States
- EVGN Israel
- Employees
- PRPO N/A
- EVGN N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- EVGN Agricultural Chemicals
- Sector
- PRPO Industrials
- EVGN Industrials
- Exchange
- PRPO Nasdaq
- EVGN Nasdaq
- Market Cap
- PRPO 8.8M
- EVGN 9.7M
- IPO Year
- PRPO N/A
- EVGN N/A
- Fundamental
- Price
- PRPO $6.51
- EVGN $1.78
- Analyst Decision
- PRPO
- EVGN Strong Buy
- Analyst Count
- PRPO 0
- EVGN 1
- Target Price
- PRPO N/A
- EVGN $12.00
- AVG Volume (30 Days)
- PRPO 8.3K
- EVGN 66.7K
- Earning Date
- PRPO 11-06-2024
- EVGN 03-06-2025
- Dividend Yield
- PRPO N/A
- EVGN N/A
- EPS Growth
- PRPO N/A
- EVGN N/A
- EPS
- PRPO N/A
- EVGN N/A
- Revenue
- PRPO $17,411,000.00
- EVGN $7,478,000.00
- Revenue This Year
- PRPO $75.18
- EVGN $90.35
- Revenue Next Year
- PRPO N/A
- EVGN $38.71
- P/E Ratio
- PRPO N/A
- EVGN N/A
- Revenue Growth
- PRPO 31.31
- EVGN 30.69
- 52 Week Low
- PRPO $4.31
- EVGN $1.20
- 52 Week High
- PRPO $7.30
- EVGN $10.40
- Technical
- Relative Strength Index (RSI)
- PRPO 64.52
- EVGN 56.65
- Support Level
- PRPO $6.00
- EVGN $1.45
- Resistance Level
- PRPO $6.34
- EVGN $2.01
- Average True Range (ATR)
- PRPO 0.37
- EVGN 0.13
- MACD
- PRPO 0.09
- EVGN 0.01
- Stochastic Oscillator
- PRPO 100.00
- EVGN 58.34
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.